Senestech (SNES) Stock Price, News & Analysis

Company Overview

SenesTech, Inc. (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction. Administered through tamper-resistant bait stations, ContraPest delivers a proprietary formulation designed to lower fertility in target populations of Norway rats and roof rats. SenesTech complements its product offering with consultation and support services, assisting customers in designing monitoring programs, interpreting data, and implementing integrated pest management strategies tailored to municipal, commercial, and industrial settings.

Founded in 2001 and headquartered in Prescott, Arizona, SenesTech secured EPA approval for ContraPest in 2016, marking a milestone as the first fertility control agent for rodents available on the market. Since then, the company has expanded its distribution network across North America, serving food processing facilities, hospitality venues, healthcare institutions, warehouses, and municipal vector control agencies. SenesTech continues to pursue research and development of next-generation fertility control technologies and to explore potential applications in emerging global pest and wildlife management markets.

Led by an executive team with backgrounds in biotechnology, environmental science, and pest management, SenesTech is governed by a board of directors comprising industry experts in commercial product development and regulatory affairs. The company’s management structure supports ongoing collaboration with regulatory agencies and commercial partners to advance innovative solutions that address public health and sustainability concerns associated with rodent infestations.

Key Stats

• Today's Range: $4.84 to $5.26
• 50-Day Range: $4.37 to $6.15
• 52-Week Range: $1.30 to $6.24
• Volume: 176,835 shs
• Average Volume: 94,409 shs
• Market Capitalization: $25.44 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $10.00
• Consensus Rating: Buy

Senestech Stock Analysis - MarketRank™

Senestech scored higher than 57% of companies evaluated by MarketBeat, and ranked 501st out of 954 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.9 / 5
• Analyst Rating: Buy

Consensus Rating

Senestech has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

Senestech has a consensus price target of $10.00, representing about 94.2% upside from its current price of $5.15.

Amount of Analyst Coverage

Senestech has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Senestech are expected to grow in the coming year, from ($10.22) to ($6.24) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Senestech is -0.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Senestech is -0.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Senestech has a P/B Ratio of 2.13. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.24% of the float of Senestech has been sold short.

Short Interest Ratio / Days to Cover

Senestech has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Senestech has recently decreased by 22.80%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Senestech does not currently pay a dividend.

Dividend Growth

Senestech does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

2.24% of the float of Senestech has been sold short.

Short Interest Ratio / Days to Cover

Senestech has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Senestech has recently decreased by 22.80%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.96

News Sentiment

Senestech has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Senestech this week, compared to 1 article on an average week.

MarketBeat Follows

Only 1 people have added Senestech to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Senestech insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 5.29% of the stock of Senestech is held by insiders.

Percentage Held by Institutions

Only 5.19% of the stock of Senestech is held by institutions.

SNES Stock Analysis - Frequently Asked Questions

How have SNES shares performed this year?

Senestech's stock was trading at $3.31 at the beginning of 2025. Since then, SNES stock has increased by 55.6% and is now trading at $5.15.

How were Senestech's earnings last quarter?

Senestech, Inc. (NASDAQ:SNES) posted its quarterly earnings results on Thursday, August, 7th. The company reported ($0.87) EPS for the quarter. The business had revenue of $0.63 million for the quarter. Senestech had a negative net margin of 289.01% and a negative trailing twelve-month return on equity of 150.93%.
Read the conference call transcript.

When did Senestech's stock split?

Shares of Senestech reverse split on the morning of Thursday, July 25th 2024.The 1-10 reverse split was announced on Tuesday, July 23rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 24th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

When did Senestech IPO?

Senestech (SNES) raised $15 million in an initial public offering on Thursday, December 8th 2016. The company issued 1,900,000 shares at a price of $8.00 per share. Roth Capital Partners acted as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager.

Who are Senestech's major shareholders?

Top institutional investors of Senestech include Corsair Capital Management L.P. (2.23%), Jane Street Group LLC (1.41%) and Geode Capital Management LLC (0.52%).
View institutional ownership trends.

How do I buy shares of Senestech?

Shares of SNES stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Senestech own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Senestech investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CymaBay Therapeutics (CBAY), GE Aerospace (GE), Arista Networks (ANET) and Adobe (ADBE).

Company Calendar

• Last Earnings: 8/07/2025
• Today: 9/14/2025
• Next Earnings (Estimated): 11/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Chemicals
• Current Symbol: NASDAQ:SNES
• CIK: 1680378
• Web: www.senestech.com
• Phone: (928) 779-4143
• Fax: N/A
• Employees: 30
• Year Founded: 2003

Price Target and Rating

• Average Price Target for Senestech: $10.00
• High Price Target: $10.00
• Low Price Target: $10.00
• Potential Upside/Downside: +94.2%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($5.44)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$6.18 million
• Net Margins: -289.01%
• Pretax Margin: -289.01%
• Return on Equity: -150.93%
• Return on Assets: -111.41%

Debt

• Debt-to-Equity Ratio: 0.03
• Current Ratio: 9.23
• Quick Ratio: 8.35

Sales & Book Value

• Annual Sales: $1.86 million
• Price / Sales: 13.68
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.42 per share
• Price / Book: 2.13

Miscellaneous

• Outstanding Shares: 4,940,000
• Free Float: 4,682,000
• Market Cap: $25.44 million
• Optionable: Not Optionable
• Beta: 0.27